Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancerRachel M. Layman, Charles L. Shapiro, Bhuvaneswari Ramaswamy et al.|Cancer Chemotherapy and Pharmacology|2013Cited by 47
Phase I trial of the PARP inhibitor veliparib (V) in combination with carboplatin (C) in metastatic breast cancer (MBC).Robert Wesolowski, Bhuvaneswari Ramaswamy, Meng Zhao et al.|Journal of Clinical Oncology|2014Cited by 16